等待开盘 08-06 09:30:00 美东时间
0.000
0.00%
After GSK (GSK) announced it would discontinue a chronic cough therapy following a late-stage trial failure, Trevi Therapeutics (TRVI), which is advancing a rival candidate, traded higher to reach an ...
07-18 02:04
葛兰素史克(GSK)启动camlipixant肠易激综合征适应症2期临床试验BALANCE,试验编号NCT07519395,针对腹泻型、混合型肠易激综合征成年患...
06-26 00:53
An update from GRP Ltd. ( ($SG:BLU) ) is now available. GRP Limited has announc...
2025-10-29 18:12
GRP Ltd. ( ($SG:BLU) ) just unveiled an update. GRP Ltd. has announced that it ...
2025-10-21 18:12
GRP Ltd. ( ($SG:BLU) ) has shared an update. GRP Limited, a company incorporate...
2025-06-30 19:23
The latest announcement is out from GRP Ltd. ( ($SG:BLU) ). GRP Limited, incorp...
2025-06-26 20:17
Goldman Sachs compiled research suggesting the global pharmaceutical sector has approximately $700 billion available for M&A and investments. This significant financial reserve will be crucial as patents for some of the industry's blockbuster drugs are on the expiration cliff.
2023-07-08 01:18
RBC Capital analyst Gregory Renza reiterates BELLUS Health (NASDAQ:BLU) with a Sector Perform and maintains $14.75 price target.
2023-05-15 20:43